focus -WSS

focus

author：focus 2025-09-29 21:28:07 - browse：295

A liver with a smooth and healthy left half and a bumpy, browning right half — chronic disease coverage from STAT — Adobe

Akero Therapeutics said Monday that extending treatment with its experimental drug for the liver disease known as MASH from six months to two years resulted in better outcomes for patients — most notably reductions in liver scarring at a rate three times higher than placebo without worsening other symptoms.

The mid-stage study of the Akero drug called efruxifermin achieved its main goal in September 2022. With longer treatment, more patients with MASH responded to the drug, while those who initially benefited showed durable improvements.

“We’re really pleased with the data. It’s exactly what we were hoping to see,” said Kitty Yale, Akero’s chief development officer, in an interview with STAT. “It’s not just the high response rates, but the fact that responses are sustained and broadened as well.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： The problems with dementia villages

Wikipedia

WSS

Mom launches Girl Scout troop for LGBTQ youth in Texas

Readout LOUD podcast: Live from the 2023 STAT Summit

ADCs take center stage as promising cancer treatments

UnitedHealth, Optum discontinue NaviHealth name

Millions may soon lose Medicaid when they don't have to

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

entertainment

focus

focus

The cancer drug shortage isn’t new — and neither are the solutions

How AI can help patients find reliable information about doctors

At least 13 dead in Texas as scorching temps continue

Sea level rise could wash away turtle breeding grounds around the world, researchers say

The cancer drug shortage isn’t new — and neither are the solutions

The problems with dementia villages

Trump demands the U.S. pay no more for drugs than other countries … again

J&J lung cancer data amount to new salvo against AstraZeneca

Drug repurposing or repositioning? The language matters

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

entertainment

Can medical device makers keep up in the race to treat obesity?

How to fix the rural physician shortage in the U.S.

How to fix the rural physician shortage in the U.S.

Millions may soon lose Medicaid when they don't have to

Inside the rise of 'mukbang' eating videos

How AI can help patients find reliable information about doctors

entertainment

Wikipedia

focus

hotspot